Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture

被引:20
作者
Janulionis, E [1 ]
Sofer, C [1 ]
Song, HY [1 ]
Wallis, RS [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA
关键词
D O I
10.1128/AAC.48.8.3133-3135.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activity of oral clofazimine against intracellular Mycobacterium tuberculosis was compared to that of ofloxacin in healthy volunteers by the use of whole-blood cultures. Clofazimine was inactive whether it was tested alone or combined with other drugs that are used to treat multidrug-resistant tuberculosis, despite a total dose of 2 g. Kanamycin was the most active drug tested.
引用
收藏
页码:3133 / 3135
页数:3
相关论文
共 16 条
[1]   Nonadherent cultures of human monocytes kill Mycobacterium smegmatis, but adherent cultures do not [J].
Barker, K ;
Fan, HX ;
Carroll, C ;
Kaplan, G ;
Barker, J ;
Hellmann, W ;
Cohn, ZA .
INFECTION AND IMMUNITY, 1996, 64 (02) :428-433
[2]   Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms [J].
Brill, KJ ;
Li, Q ;
Larkin, R ;
Canaday, DH ;
Kaplan, DR ;
Boom, WH ;
Silver, RF .
INFECTION AND IMMUNITY, 2001, 69 (03) :1755-1765
[3]   Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis [J].
Brindle R. ;
Odhiambo J. ;
Mitchison D. .
BMC Pulmonary Medicine, 1 (1)
[4]  
Brown K N, 1978, Scand J Infect Dis Suppl, P251
[5]   Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis [J].
Cheon, SH ;
Kampmann, B ;
Hise, AG ;
Phillips, M ;
Song, HY ;
Landen, K ;
Li, Q ;
Larkin, R ;
Ellner, JJ ;
Silver, RF ;
Hoft, DF ;
Wallis, RS .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (04) :901-907
[6]  
Heifets L, 2000, INT J TUBERC LUNG D, V4, P491
[7]   Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days [J].
Jindani, A ;
Doré, CJ ;
Mitchison, DA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) :1348-1354
[8]   THERAPY OF MULTIDRUG-RESISTANT TUBERCULOSIS - LESSONS FROM STUDIES WITH MICE [J].
KLEMENS, SP ;
DESTEFANO, MS ;
CYNAMON, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2344-2347
[9]   ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion [J].
Kusner, DJ ;
Barton, JA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3308-3315
[10]   ATP-induced killing of virulent mycobacterium tuberculosis within human macrophages requires phospholipase D [J].
Kusner, DJ ;
Adams, J .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :379-388